Schroder Investment Management Group’s Maravai LifeSciences MRVI Stock Holding History

Schroder Investment Management Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-43,729	Closed	-$626K	–	1297
2022 Q4	$626K	Sell	43,729 -81,567	-65%	-$1.28M	﹤0.01%	1112
2022 Q3	$3.2M	Sell	125,296 -41,942	-25%	-$1.05M	0.01%	861
2022 Q2	$4.65M	Sell	167,238 -9,995	-6%	-$317K	0.01%	807
2022 Q1	$6.32M	Buy	177,233 +109,669	+162%	+$3.68M	0.01%	783
2021 Q4	$2.83M	Buy	67,564 +50,221	+290%	+$2.03M	﹤0.01%	864
2021 Q3	$851K	Buy	+17,343	New	+$846K	﹤0.01%	1135

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Schroder Investment Management Group's MRVI Position: Q1 2023 in Review

Schroder Investment Management Group sold out of Maravai LifeSciences (MRVI) in Q1 2023, closing a stake of 43,729 shares — an estimated $626K sold.

Schroder Investment Management Group first reported a position in MRVI in Q3 2021 and held it in 6 quarters. The position peaked at $6.32M in Q1 2022. 219 funds tracked by Wall St. Rank hold MRVI as of Q1 2023.

Schroder Investment Management Group reported no remaining Maravai LifeSciences position as of Q1 2023 after selling out during the quarter.
Schroder Investment Management Group sold 43,729 Maravai LifeSciences shares in Q1 2023, an estimated $626K.
Schroder Investment Management Group first reported a position in Maravai LifeSciences in Q3 2021 and held it in 6 quarters.
Schroder Investment Management Group's Maravai LifeSciences position peaked at $6.32M in Q1 2022.
219 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2023.

Based on Schroder Investment Management Group's 13F filing for Q1 2023, filed 11 May 2023.